Report Detail
Global Gene-based Advanced Therapy Medicinal Market Growth (Status and Outlook) 2022-2028
- RnM4484364 |
- 22 August, 2022 |
- Global |
- 104 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global market for Gene-based Advanced Therapy Medicinal is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Gene-based Advanced Therapy Medicinal market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Gene-based Advanced Therapy Medicinal market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Gene-based Advanced Therapy Medicinal market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Gene-based Advanced Therapy Medicinal market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Gene-based Advanced Therapy Medicinal players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Gene-based Advanced Therapy Medicinal market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Gene-based Advanced Therapy Medicinal market, with both quantitative and qualitative data, to help readers understand how the Gene-based Advanced Therapy Medicinal market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Gene-based Advanced Therapy Medicinal market and forecasts the market size by Type (Viral Gene Delivery System and Non-viral Gene Delivery System,), by Application (Neurological Diseases, Cancer and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segmentation by application
Neurological Diseases
Cancer
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Chapter Introduction
Chapter 1: Scope of Gene-based Advanced Therapy Medicinal, Research Methodology, etc.
Chapter 2: Executive Summary, global Gene-based Advanced Therapy Medicinal market size and CAGR, Gene-based Advanced Therapy Medicinal market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Gene-based Advanced Therapy Medicinal revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Gene-based Advanced Therapy Medicinal revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Gene-based Advanced Therapy Medicinal market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Gene-based Advanced Therapy Medicinal Market Size 2017-2028
- 2.1.2 Gene-based Advanced Therapy Medicinal Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Gene-based Advanced Therapy Medicinal Segment by Type
- 2.2.1 Viral Gene Delivery System
- 2.2.2 Non-viral Gene Delivery System
- 2.3 Gene-based Advanced Therapy Medicinal Market Size by Type
- 2.3.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2017-2022)
- 2.4 Gene-based Advanced Therapy Medicinal Segment by Application
- 2.4.1 Neurological Diseases
- 2.4.2 Cancer
- 2.4.3 Other
- 2.5 Gene-based Advanced Therapy Medicinal Market Size by Application
- 2.5.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2017-2022)
3 Gene-based Advanced Therapy Medicinal Market Size by Player
- 3.1 Gene-based Advanced Therapy Medicinal Market Size Market Share by Players
- 3.1.1 Global Gene-based Advanced Therapy Medicinal Revenue by Players (2020-2022)
- 3.1.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Players (2020-2022)
- 3.2 Global Gene-based Advanced Therapy Medicinal Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Gene-based Advanced Therapy Medicinal by Regions
- 4.1 Gene-based Advanced Therapy Medicinal Market Size by Regions (2017-2022)
- 4.2 Americas Gene-based Advanced Therapy Medicinal Market Size Growth (2017-2022)
- 4.3 APAC Gene-based Advanced Therapy Medicinal Market Size Growth (2017-2022)
- 4.4 Europe Gene-based Advanced Therapy Medicinal Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Gene-based Advanced Therapy Medicinal Market Size by Country (2017-2022)
- 5.2 Americas Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022)
- 5.3 Americas Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Gene-based Advanced Therapy Medicinal Market Size by Region (2017-2022)
- 6.2 APAC Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022)
- 6.3 APAC Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Gene-based Advanced Therapy Medicinal by Country (2017-2022)
- 7.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022)
- 7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Gene-based Advanced Therapy Medicinal by Region (2017-2022)
- 8.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Gene-based Advanced Therapy Medicinal Market Forecast
- 10.1 Global Gene-based Advanced Therapy Medicinal Forecast by Regions (2023-2028)
- 10.1.1 Global Gene-based Advanced Therapy Medicinal Forecast by Regions (2023-2028)
- 10.1.2 Americas Gene-based Advanced Therapy Medicinal Forecast
- 10.1.3 APAC Gene-based Advanced Therapy Medicinal Forecast
- 10.1.4 Europe Gene-based Advanced Therapy Medicinal Forecast
- 10.1.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast
- 10.2 Americas Gene-based Advanced Therapy Medicinal Forecast by Country (2023-2028)
- 10.2.1 United States Gene-based Advanced Therapy Medicinal Market Forecast
- 10.2.2 Canada Gene-based Advanced Therapy Medicinal Market Forecast
- 10.2.3 Mexico Gene-based Advanced Therapy Medicinal Market Forecast
- 10.2.4 Brazil Gene-based Advanced Therapy Medicinal Market Forecast
- 10.3 APAC Gene-based Advanced Therapy Medicinal Forecast by Region (2023-2028)
- 10.3.1 China Gene-based Advanced Therapy Medicinal Market Forecast
- 10.3.2 Japan Gene-based Advanced Therapy Medicinal Market Forecast
- 10.3.3 Korea Gene-based Advanced Therapy Medicinal Market Forecast
- 10.3.4 Southeast Asia Gene-based Advanced Therapy Medicinal Market Forecast
- 10.3.5 India Gene-based Advanced Therapy Medicinal Market Forecast
- 10.3.6 Australia Gene-based Advanced Therapy Medicinal Market Forecast
- 10.4 Europe Gene-based Advanced Therapy Medicinal Forecast by Country (2023-2028)
- 10.4.1 Germany Gene-based Advanced Therapy Medicinal Market Forecast
- 10.4.2 France Gene-based Advanced Therapy Medicinal Market Forecast
- 10.4.3 UK Gene-based Advanced Therapy Medicinal Market Forecast
- 10.4.4 Italy Gene-based Advanced Therapy Medicinal Market Forecast
- 10.4.5 Russia Gene-based Advanced Therapy Medicinal Market Forecast
- 10.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast by Region (2023-2028)
- 10.5.1 Egypt Gene-based Advanced Therapy Medicinal Market Forecast
- 10.5.2 South Africa Gene-based Advanced Therapy Medicinal Market Forecast
- 10.5.3 Israel Gene-based Advanced Therapy Medicinal Market Forecast
- 10.5.4 Turkey Gene-based Advanced Therapy Medicinal Market Forecast
- 10.5.5 GCC Countries Gene-based Advanced Therapy Medicinal Market Forecast
- 10.6 Global Gene-based Advanced Therapy Medicinal Forecast by Type (2023-2028)
- 10.7 Global Gene-based Advanced Therapy Medicinal Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Biogen
- 11.1.1 Biogen Company Information
- 11.1.2 Biogen Gene-based Advanced Therapy Medicinal Product Offered
- 11.1.3 Biogen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Biogen Main Business Overview
- 11.1.5 Biogen Latest Developments
- 11.2 Novartis
- 11.2.1 Novartis Company Information
- 11.2.2 Novartis Gene-based Advanced Therapy Medicinal Product Offered
- 11.2.3 Novartis Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Novartis Main Business Overview
- 11.2.5 Novartis Latest Developments
- 11.3 Gilead Sciences
- 11.3.1 Gilead Sciences Company Information
- 11.3.2 Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offered
- 11.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Gilead Sciences Main Business Overview
- 11.3.5 Gilead Sciences Latest Developments
- 11.4 Sarepta Therapeutics
- 11.4.1 Sarepta Therapeutics Company Information
- 11.4.2 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
- 11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Sarepta Therapeutics Main Business Overview
- 11.4.5 Sarepta Therapeutics Latest Developments
- 11.5 Alnylam Pharmaceuticals
- 11.5.1 Alnylam Pharmaceuticals Company Information
- 11.5.2 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offered
- 11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Alnylam Pharmaceuticals Main Business Overview
- 11.5.5 Alnylam Pharmaceuticals Latest Developments
- 11.6 Amgen
- 11.6.1 Amgen Company Information
- 11.6.2 Amgen Gene-based Advanced Therapy Medicinal Product Offered
- 11.6.3 Amgen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Amgen Main Business Overview
- 11.6.5 Amgen Latest Developments
- 11.7 Spark Therapeutics
- 11.7.1 Spark Therapeutics Company Information
- 11.7.2 Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
- 11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Spark Therapeutics Main Business Overview
- 11.7.5 Spark Therapeutics Latest Developments
- 11.8 Akcea Therapeutics
- 11.8.1 Akcea Therapeutics Company Information
- 11.8.2 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
- 11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Akcea Therapeutics Main Business Overview
- 11.8.5 Akcea Therapeutics Latest Developments
- 11.9 Sunway Biotech
- 11.9.1 Sunway Biotech Company Information
- 11.9.2 Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offered
- 11.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Sunway Biotech Main Business Overview
- 11.9.5 Sunway Biotech Latest Developments
- 11.10 SIBIONO
- 11.10.1 SIBIONO Company Information
- 11.10.2 SIBIONO Gene-based Advanced Therapy Medicinal Product Offered
- 11.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 SIBIONO Main Business Overview
- 11.10.5 SIBIONO Latest Developments
- 11.11 AnGes
- 11.11.1 AnGes Company Information
- 11.11.2 AnGes Gene-based Advanced Therapy Medicinal Product Offered
- 11.11.3 AnGes Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 AnGes Main Business Overview
- 11.11.5 AnGes Latest Developments
- 11.12 Orchard Therapeutics
- 11.12.1 Orchard Therapeutics Company Information
- 11.12.2 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
- 11.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Orchard Therapeutics Main Business Overview
- 11.12.5 Orchard Therapeutics Latest Developments
- 11.13 Human Stem Cells Institute
- 11.13.1 Human Stem Cells Institute Company Information
- 11.13.2 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offered
- 11.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Human Stem Cells Institute Main Business Overview
- 11.13.5 Human Stem Cells Institute Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Gene-based Advanced Therapy Medicinal. Industry analysis & Market Report on Gene-based Advanced Therapy Medicinal is a syndicated market report, published as Global Gene-based Advanced Therapy Medicinal Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Gene-based Advanced Therapy Medicinal market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
